Literature DB >> 11311199

P-glycoprotein expression in human major and minor salivary glands.

T Uematsu1, M Yamaoka, T Matsuura, R Doto, H Hotomi, A Yamada, Y Hasumi-Nakayama, D Kayamoto.   

Abstract

Sodium pump and carbonic anhydrase activity have been described in the salivary glands. However, it remains to be elucidated whether these energy sources are used for secretion, excretion or both. In addition, the differences in the function of excretion and the role of the excretory duct cells are currently unknown in salivary glands. Expression of P-glycoprotein (P-gp), which is an ATPase-binding efflux pump, was tested in normal major and minor salivary glands from humans. P-gp was distributed on the basolateral membrane of serous acinar cells in the major salivary glands and the minor salivary glands. In particular, it was found to be present on the basolateral membrane and cytoplasm of acinar demilunar cells in the anterior lingual gland. Intense expression was identified in the basolateral membrane of the striated duct cells of the major salivary glands. P-gp was distinctly positive in the basolateral and/or luminal membranes of the initial part and in the luminal membrane of the terminal part of the excretory duct cells of the major salivary glands, whereas it was positive in the luminal membranes of both the initial part and the terminal part of the excretory duct cells of the minor salivary glands. These disparate distributions between the major and the minor salivary glands suggest different physiological excretions in the striated duct. P-gp may be physiologically involved in an important part of the transporter system, not only in the acinar serous cells and the striated duct cells, but also in the excretory duct cells in the salivary glands.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11311199     DOI: 10.1016/s0003-9969(01)00012-7

Source DB:  PubMed          Journal:  Arch Oral Biol        ISSN: 0003-9969            Impact factor:   2.633


  6 in total

1.  Is saliva a valid substitute for plasma in pharmacokinetic studies of oxycodone and its metabolites in patients with cancer?

Authors:  Janet Hardy; Ross Norris; Helen Anderson; Angela O'Shea; Bruce Charles
Journal:  Support Care Cancer       Date:  2011-04-15       Impact factor: 3.603

2.  Measurement of saliva tacrolimus levels in pediatric renal transplant recipients.

Authors:  Vladimir Belostotsky; Jo Adaway; Brian G Keevil; Dena R Cohen; Nicholas J A Webb
Journal:  Pediatr Nephrol       Date:  2010-10-24       Impact factor: 3.714

3.  Evidence of P-glycoprotein mediated apical to basolateral transport of flunisolide in human broncho-tracheal epithelial cells (Calu-3).

Authors:  B I Florea; I C van der Sandt; S M Schrier; K Kooiman; K Deryckere; A G de Boer; H E Junginger; G Borchard
Journal:  Br J Pharmacol       Date:  2001-12       Impact factor: 8.739

4.  Tacrolimus Concentration in Saliva of Kidney Transplant Recipients: Factors Influencing the Relationship with Whole Blood Concentrations.

Authors:  Mwlod Ghareeb; Reginald Y Gohh; Fatemeh Akhlaghi
Journal:  Clin Pharmacokinet       Date:  2018-09       Impact factor: 6.447

Review 5.  Polyspecific organic cation transporters and their impact on drug intracellular levels and pharmacodynamics.

Authors:  David J Wagner; Tao Hu; Joanne Wang
Journal:  Pharmacol Res       Date:  2016-06-16       Impact factor: 7.658

6.  Membrane Transporters in Human Parotid Gland-Targeted Proteomics Approach.

Authors:  Joanna Lapczuk-Romanska; Diana Busch; Ewa Gieruszczak; Agnieszka Drozdzik; Katarzyna Piotrowska; Robert Kowalczyk; Stefan Oswald; Marek Drozdzik
Journal:  Int J Mol Sci       Date:  2019-09-28       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.